HIV prevention drug in Nigeria to arrive in March, Federal Government confirms
The Federal Government of Nigeria has announced that a groundbreaking HIV prevention drug is expected to arrive in the country in March, a development that health experts say could significantly reduce the rate of new HIV infections. The announcement has generated optimism among public health stakeholders and people living with HIV, as Nigeria continues its efforts to control the spread of the virus.
According to government officials, the drug is part of a new generation of HIV prevention medication designed to offer longer-lasting protection compared to existing options. Unlike daily preventive pills, the new drug is reported to provide protection for an extended period, making it easier for people at high risk of infection to stay protected without the burden of taking medicine every day.
The Ministry of Health said the introduction of the drug would strengthen Nigeria’s HIV prevention strategy, which currently relies on a combination of awareness campaigns, condom use, testing services, and preventive medicines. Officials noted that the new medication would be distributed through designated health facilities across the country after regulatory approvals and training of healthcare workers.
Nigeria has one of the highest numbers of people living with HIV in Africa, although recent years have seen a steady decline in new infections due to improved testing and treatment programmes. Health authorities believe that the arrival of the new prevention drug could accelerate progress toward reducing transmission rates, especially among vulnerable groups.
A senior health official said the drug would initially be targeted at populations considered to be at higher risk of contracting HIV. These include sex workers, people with multiple sexual partners, and individuals in serodiscordant relationships, where one partner is HIV-positive and the other is not. The official explained that the aim is to focus on those who would benefit most from the additional layer of protection.
Public health experts welcomed the announcement, describing the drug as a major breakthrough in HIV prevention. They said its long-lasting nature could help solve one of the biggest challenges in preventive treatment, which is adherence. Many people fail to take daily preventive medication consistently, reducing its effectiveness. A longer-acting drug could improve protection by ensuring steady coverage over time.
The government also assured Nigerians that the drug would be made available at subsidised or no cost to those who qualify, as part of its commitment to universal access to HIV prevention and care. International partners are said to be supporting the initiative through funding and technical assistance, although officials did not disclose the full list of partners involved.
Civil society organisations working in the HIV sector said the move could mark a turning point in the fight against the virus. They called on the government to ensure that the drug is distributed fairly and reaches rural and underserved communities, where access to healthcare is often limited.
Some health advocates also stressed the importance of continued education and awareness. They said the new drug should not be seen as a replacement for other preventive measures, such as safe sex practices and regular testing. Instead, it should be used as part of a broader strategy to protect people and reduce stigma associated with HIV.
However, analysts warned that logistical challenges could affect the rollout of the drug. Issues such as storage, transportation, and training of medical personnel must be addressed to ensure the medicine is delivered safely and efficiently. They also urged the government to provide clear guidelines on who is eligible and how the drug can be accessed.
For people living with HIV and those at risk, the news has brought renewed hope. Many see it as a sign that scientific progress is translating into real-world solutions that can save lives and reduce suffering. Community leaders said they would work closely with health authorities to promote acceptance and proper use of the new medication.
The government reiterated that Nigeria remains committed to meeting global targets on HIV prevention and treatment. Officials said the arrival of the drug in March represents a key step in strengthening the country’s response to the epidemic and protecting future generations.
As preparations continue for the drug’s arrival, health authorities are urging Nigerians to keep using existing prevention methods and to get tested regularly. The coming months will determine how effectively the new HIV prevention drug can be integrated into Nigeria’s healthcare system and how much impact it will have on reducing new infections nationwide.
About the Author
